Starling Oncology (STLNW) Share-based Compensation Growth (3y) (2024 - 2026)
Powered by 
Analysis
Starling Oncology (STLNW) Share-based Compensation Growth (3y) (2024 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.22 Bn | 1.16 Bn | -71.94% |
| 2 | RadNet | 5.52 Bn | 4.79 Bn | 88.08 Mn | 29.35% |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | -42.43% |
| 4 | Concentra Group Holdings Parent | 4.26 Bn | 4.10 Bn | 192.10 Mn | - |
| 5 | Privia Health | 2.57 Bn | 2.15 Bn | - | 28.01% |
| 6 | Pediatrix Medical | 2.15 Bn | 1.74 Bn | - | -4.30% |
| 7 | Progyny | 2.11 Bn | 1.87 Bn | 89.30 Mn | -13.60% |
| 8 | Surgery Partners | 1.84 Bn | 1.63 Bn | 622.10 Mn | -6.17% |
| 9 | U S Physical Therapy | 1.17 Bn | 1.15 Bn | 41.94 Mn | -24.10% |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn | -36.13% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -36.13% |
| Mar 31, 2026 | -30.23% |
| Dec 31, 2025 | -39.91% |
| Sep 30, 2025 | -46.12% |
| Jun 30, 2025 | -51.31% |
| Mar 31, 2025 | -44.55% |
| Dec 31, 2024 | -62.47% |
| Sep 30, 2024 | 243.39% |
| Jun 30, 2024 | 304.96% |
| Mar 31, 2024 | 359.96% |